Conditions: Hepatitis C
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 60
Healthy volunteers: yes

Brief summary:
The objective is to investigate the bioequivalence of 2 dose strengths of 40 mg and 120 mg BI 201335 NA soft gelatine capsules.

Detailed description:

Arms:
arm 1: Test - Reference - Reference - Test arm 2: Reference - Test - Test - Reference

Interventions: intervention 1: BI 201335 NA 120 mg capsule intervention 2: BI 201335 NA 120 mg capsule intervention 3: BI 201335 NA 40 mg capsule intervention 4: BI 201335 NA 40 mg capsule
Intervention descriptions: intervention 1: 1capsule of BI 201335 NA 120 mg capsule intervention 2: 1 capsule of BI 201335 NA 120 mg capsule intervention 3: 3 capsules of BI 201335 NA 40 mg capsule intervention 4: 3 capsules of BI 201335 NA 40 mg capsule

Protocol document: